Bicycle Therapeutics (BCYC) Total Debt (2020 - 2024)

Bicycle Therapeutics has reported Total Debt for 5 years, with the latest figure at $30.9 million in Q2 2024.

• For the quarter ending Q2 2024, Total Debt rose 1.3% year-over-year to $30.9 million; the trailing twelve-month figure through Jun 2024 stood at $30.9 million (up 1.3% YoY), and the FY2023 full-year result was $30.7 million, up 1.26% from the prior year.
• Total Debt for Q2 2024 stood at $30.9 million, roughly flat from $30.8 million in the prior quarter.
• The five-year high for Total Debt was $30.9 million in Q2 2024, with the low at $14.4 million in Q3 2020.
• Historically, Total Debt has averaged $28.3 million across 5 years, with a median of $30.2 million in 2022.
• Annual changes were most pronounced in 2021 — Total Debt soared 106.23% — and 2023, when it grew 1.22%.
• Bicycle Therapeutics' Total Debt stood at $14.5 million in 2020, then jumped by 105.95% to $29.9 million in 2021, then climbed by 1.48% to $30.3 million in 2022, then gained by 1.26% to $30.7 million in 2023, then advanced by 0.69% to $30.9 million in 2024.
• The last three Total Debt figures came in at $30.9 million (Q2 2024), $30.8 million (Q1 2024), and $30.7 million (Q4 2023), per Business Quant data.